Tech Company Financing Transactions
Quanterix Funding Round
T. Rowe Price and private investors participated in a $8.5 million Series D capital raise for Quanterix. This VC investment round was announced on 6/15/2017.
Transaction Overview
Company Name
Announced On
6/15/2017
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series D
Investors
T. Rowe Price (Lead Investor)
Proceeds Purpose
The funding, which is a follow on to its Series D financing round of $46m raised in March 2016, is intended to be used to develop new instruments, expand the company's assay menu and meet global demand for its proprietary platform across therapeutic markets.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
113 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
At Quanterix (NASDAQ: QTRX), our principal focus is to improve human health by providing physicians, drug developers, and researchers with the ability to detect and analyze important biomolecules within complex biological samples at the level of single molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Hrusovsky
Chief Financial Officer
Joe Driscoll
Chief Technical Officer
David Duffy
Vice President
Dawn Mattoon
Vice President
Mark Roskey
VP - Finance
Ernest Orticerio
VP - Human Resources
Elisabeth Colunio
VP - Operations
Bruce Bal
Browse more venture capital transactions:
Prev: 6/15/2017: Fortanix venture capital transaction
Next: 6/15/2017: ZenIQ venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs